Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis우려되는 SARS-CoV-2 변종에 대한 COVID-19 백신의 효과: 체계적인 검토 및 메타 분석Meta-Analysis Published on 2022-05-232022-09-11 Journal: BMC Medicine [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI 95% confidence interval Ad26 Ad26.COV2.S Alpha Alpha variant Analysis BBIBP-CorV Beta BNT162b2 booster vaccination calculated case-control studies case-control study ChAdOx1 CIs Cohort studies cohort study conducted controlled trials CoronaVac COV2.S COVID-19 COVID-19 vaccine COVID-19 vaccines CVnCoV defined Delta delta variant Delta variants effective Effectiveness estimate evaluated Evidence Gamma Interaction Meta-analysis moderate mRNA mRNA vaccine mRNA vaccines mRNA-1273 NVX-CoV2373 omicron Omicron variants Participants random-effect Random-effects meta-analysis Randomized controlled trial RCT RCTs SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants SCB-2019 searched significant interaction systematic review vaccination Vaccine vaccine effectiveness variants variants of concern VoC [DOI] 10.1186/s12916-022-02397-y PMC 바로가기 [Article Type] Meta-Analysis
Facial Angioedema after the first dose of Covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster dosesCovishield(아데노바이러스 매개 중증 급성 호흡기 증후군 코로나바이러스 2 백신)의 첫 번째 접종 후 안면 혈관부종: 두 번째 및 세 번째 추가 접종 후 추적Case Reports Published on 2022-05-202022-09-12 Journal: Revista da Sociedade Brasileira de Medicina Tropic [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] acute respiratory syndrome allergy Angioedema booster dose ChAdOx1 contribute coronavirus doses drug facial first dose Follow-up full-length Heterologous homologous hypersensitivity mass pandemic reaction SARS-CoV-2 simian adenovirus vector Spike protein vaccination Vaccine Vaccines was recorded [DOI] 10.1590/0037-8682-0063-2022 PMC 바로가기 [Article Type] Case Reports
Development of SARS-CoV-2 variant protein microarray for profiling humoral immunity in vaccinated subjects백신 접종 대상체의 체액성 면역 프로파일링을 위한 SARS-CoV-2 변이 단백질 마이크로어레이 개발Article Published on 2022-05-152022-09-11 Journal: Biosensors & bioelectronics [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] ACE2 anti-spike antibody antibody Antibody responses AZD1222 B.1.1.7 B.1.351 B.1.617 B.1.617.1 B.1.617.2 binding ChAdOx1 chimeric collected correlated D614G demonstrated develop development domain Drug development Extracellular globe host receptor Humoral immunity Humoral response humoral responses IgA IgG IgM isotype IgM isotypes immune inhibiting Microarray MONITOR mRNA-1273 mutant neutralization neutralizing activities Neutralizing activity neutralizing antibody P.1 platform Protein protein microarray Research SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants serology serum spike variants subject the antibody response vaccinated individual vaccination Vaccine Vaccines variant variants variants of concern Virus neutralization wild-type [DOI] 10.1016/j.bios.2022.114067 PMC 바로가기 [Article Type] Article
An excitation wavelength-optimized, stable SERS biosensing nanoplatform for analyzing adenoviral and AstraZeneca COVID-19 vaccination efficacy status using tear samples of vaccinated individuals백신 접종자의 눈물 샘플을 사용하여 아데노바이러스 및 AstraZeneca COVID-19 예방 접종 효능 상태를 분석하기 위한 여기 파장 최적화된 안정적인 SERS 바이오 센싱 나노 플랫폼Article Published on 2022-05-152022-09-11 Journal: Biosensors & bioelectronics [Category] COVID19(2023년), SARS, 치료기술, [키워드] Adenovirus antibody AstraZeneca AZD1222 ChAdOx1 COVID-19 vaccination Efficacy Epidemic Epidemic keratoconjunctivitis fluids Hypothesis identify Immunoglobulin Immunoglobulin G Keratoconjunctivitis lAbel Label-free SERS biosensing platform limit of detection marker Near- and far-field properties Non-invasive Oxford-AstraZeneca Oxford-AstraZeneca vaccine Patient platform product receive reproducibility robust robustness scattering stability Stability and robustness Standard deviation Tear Tear fluids. tears the vaccine vaccinated individual vaccinated individuals vaccination Vaccination Status Vaccine [DOI] 10.1016/j.bios.2022.114079 PMC 바로가기 [Article Type] Article
Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021우려의 변종 및 예방 접종 이후 시간에 따른 SARS-CoV2 감염의 전파에 대한 백신 효과, 벨기에 접촉 추적, 2021Article Published on 2022-05-112022-09-11 Journal: Vaccine [Category] COVID19(2023년), SARS, 변종, [키워드] Ad26 Ad26.COV2.S adjusted affected age Alpha Bayesian Bayesian analysis BNT162b2 ChAdOx1 Characteristics Complete Contact Contact tracing Course COVID19 decrease Delta Effectiveness faster household hybrid Immunity IMPROVE increase in Infection infectiousness initial less mRNA mRNA-1273 mRNA-vaccines Older onward transmission reduced replacement SARS-CoV2 Sex susceptibility Transmission vaccination Vaccine vaccine effectiveness Vaccine-induced immunity Vaccines variant Viral vector Viral vector vaccines VoC waned [DOI] 10.1016/j.vaccine.2022.04.025 PMC 바로가기 [Article Type] Article
Humoral Immune Response Diversity to Different COVID-19 Vaccines: Implications for the “Green Pass” Policy다양한 COVID-19 백신에 대한 체액 면역 반응 다양성: "그린 패스" 정책에 대한 시사점Article Published on 2022-05-112022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] ACE2 binding activities Ad26 Ad26.COV2.S age Analysis anti-RBD anti-RBD antibody titer antibody Antibody Response Antibody titer appear assumption average binding BNT162b2 booster vaccination ChAdOx1 ChAdOx1 nCoV-19 ChAdOx1 nCoV-19 vaccine ChAdOx1 nCoV-19 vaccines concentrations country COV2.S COVID-19 COVID-19 infection COVID-19 pandemic detect Diversity elicit elicited eligibility epitope evaluated Features green Green Pass Policy heterogeneous humoral humoral immune response immune Immunity implication individual maintain mRNA mRNA-1273 Neutralizing Neutralizing activity Neutralizing antibodies neutralizing antibody observé Pass peptides Policy Protein Randomly Rapid test rationale RBD RBD-ACE2 reactivity reactogenicity Receptor-binding domain reduce reopening response Safe SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 spike selected sera serum serum sample significantly spike Spike protein synthetic peptide the receptor-binding domain titer vaccinated individual vaccination Vaccine virus spread [DOI] 10.3389/fimmu.2022.833085 PMC 바로가기 [Article Type] Article
Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variantsDelta 및 Omicron 변이체에 대한 COVID-19 백신 반응 및 3차 추가접종량 유도 중화항체의 비교 분석Article Published on 2022-05-052022-09-11 Journal: Nature Communications [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술, [키워드] Adenovirus adenovirus vector vaccine anti-SARS-CoV-2 antibody antibody levels BNT162b2 booster ChAdOx1 Combination Comparative analysis COVID-19 COVID-19 vaccine cross-protective Delta delta variant dose Dosing Europe fold Health care Health care worker health care workers increase indicate induce janssen mRNA mRNA vaccine mRNA vaccines mRNA-1273 mRNA-1273 booster Neutralizing antibodies neutralizing antibody of BNT162b2 omicron optimization regime response second dose variant variants [DOI] 10.1038/s41467-022-30162-5 PMC 바로가기 [Article Type] Article
Nosocomial Outbreak by Delta Variant From a Fully Vaccinated Patient완전 예방 접종을 받은 환자의 Delta 변이에 의한 병원 발병Article Published on 2022-05-022022-09-11 Journal: Journal of Korean medical science [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Admission Airborne transmission airflow Care Caregiver CCTV ChAdOx1 ChAdOx1 nCoV-19 close contact Contact contact with coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 Delta delta variant diagnosed with COVID-19 Diagnosis dominant driven by equipment FIVE had no healthcare worker hospital index case individual Inpatient nosocomial occurred outbreak Patient performed polymorphism positive Sample SARS-CoV-2 severe acute respiratory syndrome Coronavirus single-nucleotide single-nucleotide polymorphism Symptom tested vaccinated individual vaccination variant virus ward WGS whole-genome sequencing [DOI] 10.3346/jkms.2022.37.e133 PMC 바로가기 [Article Type] Article
Concurrent vaccination of kidney transplant recipients and close household cohabitants against COVID-19신장이식 수혜자와 가까운 동거인의 코로나19 동시 예방접종Article Published on 2022-05-012022-09-12 Journal: Kidney international [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Abstract BNT162b2 ChAdOx1 close household contact cohabitant concurrent COVID-19 kidney kidney transplant kidney transplant recipient ring vaccination SARS-CoV-2 vaccination [DOI] 10.1016/j.kint.2022.02.015 PMC 바로가기 [Article Type] Article
Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: a test-negative design study브라질 리우데자네이루의 사회적 취약 지역 사회에서 COVID-19에 대한 ChAdOx1 nCoV-19의 백신 효과: 테스트 음성 설계 연구Article Published on 2022-05-012022-09-11 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI adjusted age Asymptomatic individuals Brazil ChAdOx1 ChAdOx1 nCoV-19 ChAdOx1 nCoV-19 against circulating Community conducted COVID-19 COVID-19 infection Delta effective Effectiveness first and second dose first dose Gamma Infection logistic regression models median time negative test positive predominant Primary outcome qPCR test reducing Rio de Janeiro RT-qPCR RT-qPCR test second dose secondary outcome selected Symptom symptomatic symptomatic COVID-19 Test-negative the median vaccination Vaccine variant Vulnerable community. was obtained [DOI] 10.1016/j.cmi.2022.01.032 PMC 바로가기 [Article Type] Article